15 April 2024
15 April 2024
In the SMART trial, 87% of the 716 participants were women, who typically have smaller aortic annuli.
The US Food and Drug Administration (FDA) has cleared Sight Sciences’ OMNI surgical system to reduce intraocular pressure in patients with primary open-angle glaucoma.
The integration of the Hailie Smartinhaler with AstraZeneca’s medications allows real-time data collection for patients.
The new facility will produce the Co-Dx Pro instrument and test cups for the new platform.
The approval allows Illumina to offload cancer test-maker Grail either through a trade sale or a capital markets transaction.
The two companies will advance new tests for the Vivalytic analysis platform.
The Orbiter Med integrates Kalogon’s APM system with the individualised postural support.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Per GlobalData, the immunochemistry analyzers market was valued at $1.41 billion in 2023 and is expected to grow at a CAGR of >4% during 2023-2033. Leverage our latest report to develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline, while also tracking device sales in the global and country-specific immunochemistry analyzers market from 2015-2033.
Per GlobalData, the immunochemistry analyzers market was valued at $1.41 billion in 2023 and is expected to grow at a CAGR of >4% during 2023-2033. Leverage our latest report to develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline, while also tracking device sales in the global and country-specific immunochemistry analyzers market from 2015-2033.
Give your business an edge with our leading industry insights.
